<DOC>
	<DOCNO>NCT00646048</DOCNO>
	<brief_summary>This study prospective observational study examine safety TriVascular AAA Stent-Graft System elective treatment patient abdominal aortic aneurysm . Specifically , study evaluate safety TriVascualr AAA Stent-Graft System , evaluate ability deliver Tri-Vascular AAA Stent-Graft System desire location within aorta , evaluate ability TriVascular AAA Stent-Graft exclude abdominal aortic aneurysm .</brief_summary>
	<brief_title>A Phase I Evaluation Safety TriVascular Stent-Graft System Treatment Abdominal Aortic Aneurysms</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm , Abdominal</mesh_term>
	<criteria>Male infertile female Have sign inform consent form . Are consider appropriate candidate open surgical repair abdominal aortic aneurysm . least one following : Abdominal aortic aneurysm &gt; = 4.5 cm diameter ; aneurysm increase size 0.5cm last 6 month ; maximum diameter aneurysm exceed 1.5 time transverse dimension adjacent normal aortic segment ; saccular aneurysm large 3 cm . Have patent iliac femoral artery allow endovascular access aneurysmal site 17F Delivery Catheter . A dissecting , acutely rupture , leak aneurysm , acute vascular injury due trauma . A need emergent surgery . contraindication undergo angiography . A Thoracic aortic aneurysm require treatment . Presence thrombus atheroma proximal aortic neck cover &gt; 50 % endoluminal surface . Presence diffuse atherosclerotic disease either common iliac artery reduce iliac artery diameter &lt; 7mm . Congenital abnormality placement stentgraft cause occlusion major arterial flow . Such abnormality evaluate ( e.g . angiography CT ) prior treatment . Unstable angina Morbid obesity clinical condition severely inhibit xray visualization aorta . Connective tissue disease ( e.g. , Marfan 's EhlersDanlos syndrome . ) Hypercoagulable state . Contraindication anticoagulation . Acute renal failure . Active systemic infection . le 18 year age . Life expectancy less 1 year . Current , anticipated participation within 1 year , another research study involve investigational device new drug ( exception participation Lifeline Registry Endovascular Therapy ) . Other medical , social , psychological issue opinion investigator preclude receive treatment , procedure evaluation pre posttreatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Abdominal Aortic Aneurysm</keyword>
	<keyword>AAA</keyword>
	<keyword>TriVascular Stent-Graft System</keyword>
	<keyword>Stent-Graft</keyword>
</DOC>